Dengue vaccine from Takeda to sell in Japan as Southeast Asia travel rises

Top Japanese drugmaker already markets shot internationally

20250302N Vaccine

Takeda's dengue vaccine is already available in Southeast Asia, Latin America and Europe. (Takeda Pharmaceutical)

Nikkei staff writers

TOKYO -- Takeda Pharmaceutical aims to sell a vaccine for dengue in Japan as more business travelers go to Southeast Asian and Latin American destinations where the mosquito-borne viral disease is prevalent.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.